Soliton Selects RESONIC™ As Brand Name for FDA-Cleared Rapid Acoustic Pulse Device
March 02, 2021 at 08:01 am EST
Share
Soliton, Inc. announced that it has selected RESONIC™ as the brand name for the Rapid Acoustic Pulse (RAP) Device. The RAP device received FDA 510(k) clearance for its tattoo indication in May 2019 and its cellulite indication in February 2021. The initial launch of the RESONIC brand for both indications is expected in Second Quarter 2021.
Soliton Inc is a medical technology company. The Company is focused on developing and commercializing products utilizing its designed acoustic shockwave technology platform referred to as Rapid Acoustic Pulse (RAP). It develops products for the removal of tattoos and the reduction of cellulite. The RAP device in coordination with the pulsed laser removes ink pigment from the macrophages. Its RAP device uses pulses of designed acoustic shockwaves to disrupt cellular structures in the dermal and subdermal tissue. It's designed shockwave allows it to target the stiffness between cellular structures and generate an effect that represents a platform technology in tattoo removal, cellulite treatment, fibrotic scar treatment and other indications. Its technology allows the disruption of targeted structures within the skin with minimal discomfort and without additional treatment-related downtime for tattoo removal or any downtime for cellulite treatment.